Clinical Report: Assessment of CDO1/CELF4 Methylation Testing for Endometrial Cancer

Overview

This study validates CDO1/CELF4 methylation analysis as a noninvasive method for detecting endometrial intraepithelial neoplasia (EIN) and endometrial cancer (EC). It compares the diagnostic efficacy of cervical brushing cells (CBCs) with invasive diagnostic curettage (D&C) samples.

Background

The rising incidence of endometrial cancer (EC) necessitates effective early detection methods. Current noninvasive approaches often lack specificity, leading to unnecessary invasive procedures. DNA methylation analysis presents a promising alternative for early detection.

Data Highlights

Key Findings

• 31 out of 226 participants were diagnosed with EIN or EC.
• CDO1 and CELF4 methylation tests showed significantly lower ΔCt values in patients with EIN or EC (P < 0.0001).
• Strong positive correlation between CBC and D&C samples for CDO1 (R = 0.86) and CELF4 (R = 0.78).
• No significant difference in diagnostic accuracy between CBC and D&C samples for the CISENDO test (P = 0.244).
• The CISENDO test achieved an AUC of 0.929 with D&C samples.

Clinical Implications

CDO1/CELF4 methylation analysis offers a reliable noninvasive method for detecting endometrial cancer and precursors, potentially reducing the need for invasive procedures. Its implementation could enhance early detection strategies for high-risk women.

Conclusion

The study supports the use of CDO1/CELF4 methylation analysis in cervical brushing samples as an effective tool for early detection of endometrial cancer, with comparable efficacy to traditional invasive methods.

Related Resources & Content

1. Frontiers, Source, 2026 -- Validation of a Cervical CDO1/CELF4 Methylation Test for Endometrial Cancer: A Prospective Paired-Sample Comparison with Intrauterine Specimen
2. conexiant — Vaginal DNA Assay Shows Promise
3. American Journal of Epidemiology — Differential Methylation and Variability Across the Epigenome as Indicators of High-Grade Cervical Intraepithelial Neoplasia (CIN2+)
4. Systematic Review of Paired Samples Reveals DNA Methylation Biomarkers in Blood, Stool, Urine, and Tissue for Colorectal Cancer
5. The Role of Longitudinal ctDNA Assessment via Multiplex MS-ddPCR in Risk Stratification and Monitoring for Rectal Cancer
6. ACOG Publishes Updated Guidance on Evaluation of Postmenopausal Bleeding | ACOG
7. Frontiers | Validation of a Cervical CDO1/CELF4 Methylation Test for Endometrial Cancer: A Prospective Paired-Sample Comparison with Intrauterine Specimen